Denali Therapeutics Inc. (DNLI) fell -5.79% or -1.26 to $20.51. It is about 418377 shares traded, which is 134.35% compare to the average total volume 311419. The market cap of DNLI is $1.95 billion. The year to date change is 6.83%. The 52 week price range is from $12.32 to $23.28. Price of DNLI have changed -0.64% during last week. It have changed 15.74% over last month, 14.94% over last 3 months, 9.29% over last 6 months and -3.46% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for DNLI is 20.36. It is -0.73% below current price. The stock is at support level of 50-day moving averages. The 200-day Moving Averages for DNLI is 18.23. It is -11.12% below current price. The 52-week High is 23.28. It is 13.51% from the current price. The 52-week Low is 12.32. It is -39.93% from current price.
There are some statistics of DNLI. It is has market cap $1.95 billion. The share outstanding is 94.96 million. The average volume is 311419. The percent of top 15 Institution holding is 93.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of DNLI is -41.77%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of DNLI is -36.21%.